bufalin has been researched along with osimertinib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, F; Gong, YB; Kang, XH; Liao, MJ; Lu, ZH; Miao, ZH; Wang, Y; Xu, ZY; Zhao, KL | 1 |
1 other study(ies) available for bufalin and osimertinib
Article | Year |
---|---|
Degradation of MCL-1 by bufalin reverses acquired resistance to osimertinib in EGFR-mutant lung cancer.
Topics: Acrylamides; Aniline Compounds; Animals; Antineoplastic Agents; Bufanolides; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; Fluorescent Antibody Technique; Genes, erbB-1; In Situ Nick-End Labeling; Lung Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Transplantation | 2019 |